Skip to main content

Williams David Michael's Form 4 filing

Merck & Co., Inc. (MRK) · filed Feb 6, 2026

Accession no.
0000310158-26-000044
Filed
Feb 6, 2026
Trade date
Feb 6, 2026
Filing delay
Same day
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $609.5K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Williams David MichaelCIK 0001820958Officer (EVP,Chief Info&Digital Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 6, 2026Common StockMOption exerciseAcquired+5,000$77.62+$388,10035,837.74Direct
Feb 6, 2026Common StockSSaleDisposed−5,000$121.91−$609,55030,837.74Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 6, 2026Common StockMOption exerciseDisposed−5,000$0.00$04,600Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)